What's in a name?
Linked Article The following letter by Tucker & Miners, together with the response from J.K. Aronson published in this issue (http://dx.doi.org/10.1111/j.1365-2125.2011.03910.x), should be read in association with previously-published letters by C. Page (Br J Clin Pharm, 70: 912–913; http://dx.doi.org/10.1111/j.1365-2125.2010.03769.x) and J.D. Fitzgerald (Br J Clin Pharm, 71: 471–472; http://dx.doi.org/10.1111/j.1365-2125.2010.03842.x). The correspondence in its entirety relates to A manifesto for clinical pharmacology from principles to practice (Aronson JK. Br J Clin Pharm, 70: 3–13; http://dx.doi.org/10.1111/j.1365-2125.2010.03699.x).
Emeritus Professor Geoffrey T. Tucker, Simcyp Ltd, Blades Enterprise Centre, John St., Sheffield S24SU, UK.
No abstract is available for this article.